top of page

Experienced. Dedicated. Determined.

The team at Meissa is dedicated and determined to advance life-saving vaccines against respiratory viruses. Our team brings more than 200 years of experience from discovery to commercial stage for vaccine development. Collectively our team has completed more than 100 clinical trials and been involved in the development of 15 approved products.

Meissa Vaccines - Frank Galvin 06012022 v1.jpg

Frank Glavin

Chief Executive Officer

Meissa Vaccines - Keith v3A 10222021.jpg

Keith H. Wells, Ph.D.

Chief Manufacturing Officer

Meissa Jay Lieberman Headshot 10052021 v2.jpg

Jay Lieberman, M.D.

Vice President of Clinical Development

Meissa Vaccines - Marty v2A 10222021.jpg

Marty Moore Ph.D.

Founder and Chief Scientific Officer

Meissa Vaccines - Fiona v2A 10222021.jpg

Fiona Cameron

Vice President of Regulatory Affairs

Meissa Vaccines - George v2A 10222021.jpg

George Trager, MBA

Senior Director of CMC

Meissa Vaccines - Roderick v2A 10222021.jpg

Roderick Tang, Ph.D.

Founder and Senior Vice President of Research and Development

Meissa Vaccines - Janelle v2A 10222021.jpg

Janelle Muranaka

Vice President of Operations

bottom of page